Start Your Search
Poster Display session (Friday) (ID 65)
- Event: ELCC 2018
- Type: Poster Display session
- Presentations: 1
- Coordinates: 4/13/2018, 12:30 - 13:00, Hall 1
231P_PR - Impact of the continuity of nursing care delivered by a pivot nurse in oncology on improving satisfaction and quality of life of patients with advanced lung cancer (ID 270)
12:30 - 13:00 | Author(s): M. Floresci
Health care organizations around the globe have been implementing different strategies aimed at improving their care systems to obtain better patient- physician interaction and resolve underlying issues leading to patient dissatisfaction. In an effort to improve continuity of care inside a network of interdisciplinary teams, the Ministry of Health and Social Services of Québec has implemented the recruitment of pivot nurses in oncology services.
This study was conducted at the Notre Dame university hospital in Montreal. Patients were selected from the outpatient admissions’ list, three months after the start of their treatment, and divided into two cohorts: the continuity of care (CC) cohort, where patients were followed by a PNO, and the usual care (UC) cohort, who received standard care from the oncology clinic staff. Participants in both groups completed the Princess Margaret Hospital Patient Satisfaction with Doctor Questionnaire (PMH/PSQ-MD), the FACT-L Scale for quality of life assessment and questions evaluating the understanding of their health status and disease. Another ten questions were addressed specifically to the CC in regards to nursing care and the health care system in Quebec.
In total, 65 patients were recruited, 82% of whom were assigned to the CC cohort. Analysis of the PMH PSQ-MD questionnaire demonstrated superior outcomes in regards to information exchange, empathy, and quality of life for the CC cohort (p < .001). The FACT-L questionnaire also favored the CC cohort in terms of physical well being, social and family well being, emotional well being, and functional well being. These differences were highly significant and translated into better satisfaction when comparing the total score of the CC cohort to the UC cohort (p < .0001). Other variables examined revealed an adequate fulfilment of the PNO role as regarded by the participants, except for matters of an intimate nature.
The PNO appears to have a substantial role in the care of patients with advanced lung cancer. Continuity of care seems to improve patients’ quality of life and satisfaction by reducing the symptom strain experienced in the ambulatory patients.
Clinical trial identification:
Legal entity responsible for the study:
Centre Hospitalier de l'Université de Montréal
Has not received any funding
E. Kassouf: Personal fees from Lilly, Sanofi Canada, Amgen, Celgene, and Bristol-Myers Squibb outside the submitted work. M. Tehfe: Personal fees from Lilly, Amgen, and Celgene outside the submitted work. M. Floresci: Personal fees from Lilly, Merck, and Boehringer Ingelheim outside the submitted work. N. Blais: Personal fees from Merck, Pfizer, AstraZeneca, and Bristol-Myers Squibb outside the submitted work.
Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.